Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Novo Nordisk

Article Abstract:

The shares of Novo Nordisk have below-average price appreciation potential over the 2010-2012 timeframe. The Princeton, New Jersey-based company provides insulin and diabetes-care products, and treatments for coagulation disorders, and hormone replacement therapy products.

Author: Ferro, Mario
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Pharmaceutical industry, Novo Nordisk A/S

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Allegheny Tech

Article Abstract:

The price appreciation potential of the shares of Allegheny Technologies Inc. for the years 2010-2012 is discussed. The Pittsburgh, Pennsylvania-based company produces specialty metals. It operates in flat-rolled products, high-performance metals, and engineered products.

Author: Silva, Dominic B.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Securities issued, listed, Secondary Smelting, Refining, and Alloying of Nonferrous Metal (except Copper and Aluminum), Primary metal products, not elsewhere classified, Specialty Metals & Composites, United States, Stocks, Company securities, ATI, Allegheny Technologies Inc., Specialty metals industry, Analyst report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Evaluation, Securities, Stock prices
Similar abstracts:
  • Abstracts: Vonage Holdings. Applied Ind. Tech
  • Abstracts: Lubrizol Corp. Minerals Tech
  • Abstracts: Powerwave Tech
  • Abstracts: Fording Can. Coal. Peabody Energy
  • Abstracts: Aon Corp. Torchmark Corp
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.